- For confidential advice, call Alzheimer's Society's Dementia Support Line on 0333 150 3456
- Alzheimer's Society's symptoms checker can help spot the signs of dementia
- READ MORE: How to spot if someone you love has warning signs of dementia
- See more Daily Mail on Google - save us as a Preferred Source
Thousands of dementia patients are missing out on drugs that could help them live better for longer due to a damning postcode lottery.
uncertain
them → call → lottery
People living in some areas are up to nine-times more likely to be prescribed the life-changing treatments than those living elsewhere, new data from NHS England reveals.
asserted
data → live → England
Charities described the 'widespread variation' as 'alarming' and said it is 'particularly shocking' as the dementia medicines recommended by drugs watchdog NICE bring 'real benefits' to those diagnosed with the disease.
asserted
medicines → describe → disease
Evidence shows they can help people manage dementia symptoms by improving cognition, functioning and daily activities - while continued treatment may help people maintain independence for longer.
uncertain
people → show → independence
Alzheimer's Society research has found 79 per cent of people who received them felt the benefit but access is uneven across the country.
asserted
access → find → country
The National Institute for Health and Care Excellence (NICE) recommends four drugs for Alzheimer's disease, mixed dementia and dementia with Lewy bodies.
asserted
Institute → recommend → bodies
At a national level, just 25 per cent of people diagnosed with dementia were prescribed an AChEI in the last year, 23 per cent were prescribed memantine and 6.1 per cent were prescribed both an AChEI and memantine.
Someone diagnosed with dementia in North East and North Cumbria is almost nine times more likely to receive combination dementia treatment than someone in Somerset.
However, the proportion of people prescribed an AChEI ranged from 11.7 per cent in Somerset to 31.1 per cent in Lincolnshire, while the proportion prescribed memantine ranged from 9.7 per cent in Birmingham and Solihull to 35.4 per cent in Gloucestershire.
asserted
proportion → diagnose → Gloucestershire
Prescribing rates for both treatments ranged from 1.2 per cent in Somerset to 10.5 per cent in North East and North Cumbria.
asserted
rates → range → East
This means someone diagnosed with dementia in North East and North Cumbria is almost nine times more likely to receive combination dementia treatment than someone in Somerset.
asserted
someone → mean → Somerset
Michelle Dyson, chief executive of Alzheimer's Society, said: 'Our analysis of NHS prescribing data shows only a quarter of people diagnosed with dementia are receiving the treatments recommended for them.
'
asserted
quarter → say → them
It also revealed huge regional variations in who gets access.
asserted
who → reveal → access
Someone diagnosed in Gloucestershire is three times more likely to be prescribed memantine than someone in Birmingham.
asserted
Someone → diagnose → Birmingham
Someone in the North East is nearly nine times more likely to get combination treatment than someone in Somerset.
asserted
Someone → get → Somerset
It is particularly shocking as these are NICE-recommended treatments that we know bring real benefits, helping people manage symptoms and maintain their independence for longer.
asserted
people → recommend → independence
So many people appear to be missing out.
'
asserted
people → appear → ?
While we do not know exactly what lies behind these figures, we do know that a failure to invest in, and prioritise, dementia is likely to be playing a part in these high levels of regional variation.
asserted
failure → know → variation
We're calling on Government to guarantee everyone an accurate diagnosis, a care plan, and the start of appropriate treatment within 18 weeks of referral.
asserted
We → call → referral
Michelle Dyson, chief executive of Alzheimer's Society, described the 'widespread variation' as 'alarming' and said it is 'particularly shocking' as the dementia medicines recommended by drugs watchdog NICE bring 'real benefits' to those diagnosed with the disease.
'
asserted
medicines → describe → disease
This is the very least people with dementia and their families deserve.'
asserted
people → deserve → dementia
The Daily Mail and Alzheimer's Society have partnered in a drive to defeat dementia, which claims 76,000 lives a year as Britain's biggest killer.
uncertain
which → partner → killer
The Defeating Dementia campaign aims to raise awareness of the disease, in an effort to increase early diagnosis, boost research and improve care.
asserted
campaign → defeat → care
The new data does not explain why prescribing rates differ but not everyone diagnosed with dementia will be eligible for treatment, some may decline medication and some may have other health conditions that make prescribing inappropriate.
uncertain
prescribing → explain → conditions
Furthermore, some may have a type of dementia for which these medicines are not recommended.
uncertain
medicines → have → which
However, Alzheimer's Society says the scale of variation highlights the need to better understand whether inequalities exist and what factors may be driving them.
uncertain
factors → say → them
Middle-aged people with no memory problems will be prescribed a new Alzheimer's drug in a trial aiming to prevent dementia.
asserted
people → prescribe → dementia
The first participants in Europe will be screened in Britain from today, with more than 15 UK centres expected to take part in the global study.
asserted
centres → screen → study
Previous research on patients with Alzheimer's suggested the treatment could clear toxic brain plaques after just three monthly infusions.
uncertain
treatment → suggest → infusions
Now scientists will test whether giving the drug, called trontinemab, before symptoms appear can stop Alzheimer's developing in the first place.
asserted
Alzheimer → test → place
If it proves successful it has the potential to transform how the disease is treated.
asserted
disease → prove → potential
Ultimately, people at high risk could be prescribed drugs preventively in mid-life, in an approach experts have compared to 'statins for the brain'.
uncertain
experts → prescribe → brain
An NHS England spokesperson said: ‘Last year, dementia prescriptions hit a ten-year high – with five million medications given to hundreds of thousands of patients.
asserted
prescriptions → say → patients
‘However, it is not always appropriate or safe for patients with dementia to be given AChEI or memantine, and this is something that can only be decided through a medication review.
asserted
that → give → review
‘Thanks to the hard work of NHS clinicians, more than 300,000 people with dementia received a medication review in the year to March 2026.
asserted
people → receive → March
‘And we are also leading the development of a new national prescribing guidance tool, to be launched next year, which aims to reduce variation and standardise the availability of clinically and cost-effective medicines across England.’
asserted
which → lead → England
A Department of Health and Social Care spokesperson said: ‘This government is determined to improve outcomes for those living with dementia and the family members who look after them.
asserted
who → say → them
‘We are appointing a new dementia tsar to provide dedicated expertise and drive forward innovation and improvements in care.
asserted
We → appoint → care
‘And we are bringing forward the timetable for Baroness Casey's commission on social care reform to ensure the system gives people dignity, security and support when they need it most.’
asserted
they → bring → it
